ASPI
What one share of ASP Isotopes holds
Miscellaneous Chemical Products
We are an advanced materials company dedicated to the development of a differentiated isotope enrichment platform to strengthen global supply chain access to critical materials used in nuclear medicine, next-generation semiconductors, and nuclear energy.
ASP Isotopes’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.28 |
|---|---|
| Profit | −$1.19 |
| Capex (buildings and equipment) | $0.15 |
| Free cash flow | −$0.77 |
| Cash and investments | $1.69 |
| Debt | $0.46 |
| Book value | $2.03 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2022 | $0.00 | −$0.18 | $0.17 | −$0.28 | — | $0.27 |
| 2023 | $0.01 | −$0.49 | $0.07 | −$0.23 | — | $0.33 |
| 2024 | $0.07 | −$0.63 | $0.17 | −$0.47 | — | $0.66 |
| 2025 | $0.29 | −$2.11 | $0.12 | −$0.57 | — | $1.83 |